Close

Peregrine Pharma (PPHM) Bavituximab Data Presented at ImVacS

August 26, 2015 9:04 AM EDT Send to a Friend
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (NASDAQ: PPHMP) today announced the presentation of a range of clinical, translational and pre-clinical study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login